Ferrous sulfate higher concentration — Competitive Intelligence Brief

Ferrous sulfate higher concentration (Ferrous sulfate higher concentration) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

phase 2 Iron supplement Hematology Small molecule

Target snapshot

Ferrous sulfate higher concentration (Ferrous sulfate higher concentration) — Universidade Federal Fluminense. Ferrous sulfate at higher concentration provides supplemental iron to treat or prevent iron deficiency by increasing circulating iron available for hemoglobin synthesis.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ferrous sulfate higher concentration TARGET	Ferrous sulfate higher concentration	Universidade Federal Fluminense	phase 2	Iron supplement
ferrous gluconate with lactoferrin	ferrous gluconate with lactoferrin	Ain Shams University	marketed	Iron supplement with immunomodulatory adjuvant
ferrous fumarate with ascorbic acid	ferrous fumarate with ascorbic acid	Pharmacosmos A/S	marketed	Iron supplement with vitamin C enhancer
TOT'HEMA	TOT'HEMA	Laboratoire Innotech International	marketed	Iron supplement
Treatment with oral sucrosomial iron	Treatment with oral sucrosomial iron	University of Rochester	marketed	Iron supplement (oral formulation)	Iron (Fe3+) absorption pathway
F (ferrous sulphate)	F (ferrous sulphate)	Abdelwahed, Mai Mahmoud Mohamed, M.D.	marketed	Iron supplement	Iron (Fe2+) for hemoglobin and myoglobin synthesis
Iron protein succinylate oral solution	Iron protein succinylate oral solution	Lee's Pharmaceutical Limited	marketed	Iron supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class